We often highlight the countless areas of study that our antibodies can help researchers. We encourage you to check out all our primary antibodies here along with the many applications they've been used for here.

Now, the three most prominent and common uses for our antibodies are in cancer, neuroscience, and pain research. Well, what do you know? Already this month, new research has been released utilizing our antibodies in those three corresponding areas. We'd like to highlight those studies below.

Image: Staining of various glioblastoma cell lines with Neuromics Humanin antibody (cat. RA19000).

In the first study, Korean researchers used our Humanin rabbit polyclonal antibody (cat. RA19000) to study glioblastoma progression. In their release of preliminary research, the investigators found humanin to encourage glioblastoma progression via the integrin alpha V (ITGAV)–TGF beta (TGF) signaling axis. Read the full publication here.

In more preliminary findings, scientists from the University of Georgia used our Nestin mouse monoclonal antibody (cat. MO22183) in neuroscience research. The researcher wanted to better understand the role of the length of cilia in neuron development. Learn more here.

Image: Alpha 2 adrenergic receptor (cat. RA14110) labeling in the cryostat section of rat brain.

In the final piece of research, Japanese investigators wanted to better understand the link between chronic pain and attention-deficit hyperactivity disorder (ADHD). For their study, they employed our Alpha 2A Adrenergic Receptor rabbit polyclonal antibody (cat. RA14110). Check out the full publication here.